Study guide

8.5 Wound Care Formulary Management & Resource Utilization

NAWCCB WCC Wound Care Certified Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

About the NAWCCB WCC Exam How to Use This Study Guide

2 Assessment: Skin & Tissue Foundations

1.1 Skin Anatomy, Physiology, and Barrier Function 1.2 Phases of Wound Healing & Cellular Events 1.3 Acute vs. Chronic Wounds & Etiology Classification 1.4 TIME and MEASURE Assessment Frameworks 1.5 Wound Bed Tissue Types & Periwound Assessment 1.6 Pain Assessment: Scales, Wound Pain Types, and Procedural Analgesia 1.7 Psychosocial History, Cognitive Status, and Functional Assessment 1.8 Skin Integrity Across the Lifespan: Neonatal, Pediatric, Adult, and Geriatric

3 Assessment: Diagnostic Tools & Risk Assessment

2.1 Vascular Assessment: ABI, TcPO2, and Arterial/Venous Doppler 2.2 Neuropathy & Monofilament Testing in Diabetic Patients 2.3 Pressure Injury Risk Assessment: Braden Scale Subscales & Scoring 2.4 NPIAP Pressure Injury Staging (Stages 1-4, Unstageable, DTPI) 2.5 Exudate Characterization, Biofilm (NERDS/STONEES), & Wound Culture 2.6 Laboratory Interpretation in Wound Care: Albumin, Prealbumin, ESR, A1C, CBC, and CMP 2.7 Risk Assessment Instruments Beyond Braden: Norton, Braden Q, Braden QD, Wagner, and University of Texas

4 Treatment: Dressing Selection & Debridement Modalities

3.1 Principles of Dressing Selection by Exudate & Moisture Balance 3.2 High-Absorbency Dressings: Alginates, Hydrofibers, and Foams 3.3 Barrier & Hydrating Dressings: Hydrocolloids, Transparent Films, and Hydrogels 3.4 Antimicrobial & Biofilm Dressings: Silver, Cadexomer Iodine, and Honey 3.5 Debridement Modalities: Sharp, Enzymatic, Autolytic, Mechanical, & Biosurgical

5 Treatment: Advanced Therapies & Specialized Management

4.1 Negative Pressure Wound Therapy (NPWT) Indications, Settings, & Precautions 4.2 Compression Therapy Protocols & ABI Safety Cutoffs 4.3 DFU Off-loading Hierarchy: TCC, RCW, and Therapeutic Footwear 4.4 Support Surfaces, Microclimate Control, & Repositioning Protocols 4.5 Advanced Biologics, Cellular/Tissue Products (CTPs), & HBOT

6 Reevaluation & Wound Healing Trajectory

5.1 Healing Trajectory Benchmarks & Percent Area Reduction (PAR) 5.2 Serial Wound Measurement, Depth Profiling, & Digital Photography 5.3 Treatment Plan Reassessment & Non-Healing Wound Escalation Triggers 5.4 Biofilm Progression & Systemic Infection Re-evaluation 5.5 Palliative Wound Management: Odor, Exudate, and Pain Control 5.6 Validated Healing Instruments: The PUSH Tool, BWAT, and Evaluating Adherence

7 Risk Reduction & Prevention Strategies

6.1 Pressure Injury Prevention: Bundles, Turning Schedules, & Heel Floating 6.2 Moisture-Associated Skin Damage (MASD) & Incontinence-Associated Dermatitis (IAD) 6.3 Infection Control, Contact Precautions, & Environmental Hygiene 6.4 Prevention of Skin Tears & Medical Adhesive-Related Skin Injuries (MARSI) 6.5 Diabetic & Venous Ulcer Recurrence Prevention Protocols 6.6 At-Risk Populations: Spinal Cord Injury, Stroke, Critical Care, and Cognitive Impairment

8 Patient & Caregiver Education

7.1 Patient & Caregiver Wound Care Teaching & Self-Management 7.2 Diabetic Foot Self-Inspection & Footwear Education 7.3 Nutritional Assessment & Dietary Interventions for Wound Healing 7.4 Off-loading Compliance & Patient Mobility Education 7.5 Recognizing Complications, Infection Signs, & When to Seek Care 7.6 Educating the Interprofessional Team & Developing Educational Media

9 Administration & Program Management

8.1 Wound Care Documentation Standards & Clinical Records 8.2 Admission Wound Screening & Present on Admission (POA) Documentation 8.3 Interdisciplinary Team Roles & Clinical Care Coordination 8.4 Quality Improvement Metrics & HAPI Tracking Programs 8.5 Wound Care Formulary Management & Resource Utilization

10 Legal, Ethical, & Scope of Practice

9.1 Informed Consent, Treatment Refusal, & Autonomy in Wound Care 9.2 HIPAA Compliance & Clinical Photography Privacy Standards 9.3 Scope of Practice Across WCC-Eligible Professions (RN, LPN, PT, OT, DPM, MD/DO, PA) 9.4 HAPI Malpractice Liability & Documentation Defense 9.5 Ethical Considerations in Non-Healing Wounds & End-of-Life Skin Care 9.6 Regulatory Compliance, Coding Standards, & Audit Protection

8.5 Wound Care Formulary Management & Resource Utilization

Key Takeaways Explain This Topic AI

Wound care formulary management standardizes dressing selection into core functional categories (alginates, foams, hydrogels, hydrocolloids, collagens, antimicrobials) to optimize clinical outcomes and reduce supply spend.

Dressing selection must match wound bed moisture balance: absorbent dressings (foams, alginates) are indicated for heavy exudate, while hydrating dressings (hydrogels) are required for dry slough or eschar.

Total Cost of Care (TCOC) evaluation prioritizes extended dressing wear time and nursing labor savings over low unit product cost (e.g., 7-day foam vs daily wet-to-dry gauze changes).

Medicare Local Coverage Determinations (LCDs) strictly govern DME reimbursement for Negative Pressure Wound Therapy (NPWT) and surgical dressings, requiring documented 30-day failure of standard therapy and weekly measurement updates.

Formulary standardization minimizes supply room redundancy, reduces product expiration waste, and prevents inappropriate dressing application across clinical units.

Last updated: August 2026

Wound Care Formulary Management & Resource Utilization

Healthcare institutions must manage wound care supplies efficiently to maintain high standards of clinical efficacy while controlling operational costs. A structured Wound Care Formulary standardizes available products into distinct functional categories based on moisture management, antimicrobial properties, and tissue regeneration mechanisms. Uncontrolled product proliferation leads to supply room redundancy, clinician confusion, inappropriate dressing selection, product expiration waste, and inflated supply expenses.

Principles of Wound Care Formulary Standardization

A clinically effective wound care formulary is built around wound bed characteristics (the TIME framework: Tissue, Infection/Inflammation, Moisture, Edge) rather than manufacturer brand names.

Core Functional Dressing Categories

Alginates & Hydrofibers: Non-woven calcium/sodium alginate or carboxymethylcellulose fibers derived from seaweed or cellulose. Highly absorbent polymers that transform into a cohesive gel upon contact with exudate. Indication: Moderate to heavy exudate, packing deep cavities, bleeding wounds.

Foams (Hydrocellular Foams): Semi-permeable polyurethane foam sheets with moisture-vapor transmission capabilities. Indication: Moderate to heavy exudate, cushioning bony prominences, peri-wound protection. Wear time up to 7 days .

Hydrogels: Amorphous gels or impregnated sheets composed primarily of water or glycerin. Indication: Adding moisture to dry wound beds, facilitating autolytic debridement of dry slough or uninfected black eschar, painful donor sites.

Hydrocolloids: Gel-forming agents (gelatin, pectin, carboxymethylcellulose) bonded to a polyurethane film. Indication: Scant to light exudate, partial-thickness wounds, Stage 2 pressure injuries, autolytic debridement.

Collagens: Native bovine, porcine, or avian collagen matrices. Indication: Recalcitrant, clean, non-healing Stage 3/4 pressure injuries or venous leg ulcers lacking acute infection.

Antimicrobial Dressings: Dressings impregnated with sustained-release ionic Silver, Cadexomer Iodine, or Polyhexamethylene Biguanide (PHMB). Indication: Managing localized bacterial bioburden or critical colonization. Re-evaluated every 14 days .

Value-Based Care & Total Cost of Care (TCOC) Analysis

Evaluating wound care supply expenses based solely on initial unit purchase price is a major economic error. Value-based resource utilization evaluates the Total Cost of Care (TCOC) , incorporating dressing unit cost, dressing wear-time longevity, nursing labor hours required for dressing changes, and secondary complication costs.

Case Study: Wet-to-Dry Gauze vs. Hydrocellular Foam

Traditional Wet-to-Dry Saline Gauze: Low unit product cost ($1.50 per change). Requires dressing changes 2 to 3 times daily (730–1,095 changes/year). High nursing labor expense, frequent painful tissue disruption, and elevated risk of desiccation and contamination.

Modern Hydrocellular Foam Dressing: Higher initial unit cost ($12.00 per dressing). Requires dressing changes every 3 to 7 days (52–104 changes/year). Delivers superior moist wound healing, preserves granulation tissue, protects periwound skin, and saves hundreds of nursing labor hours annually. Annual TCOC = ( Dressing Unit Cost × Annual Change Frequency ) + ( Nursing Hourly Rate × Labor Hours per Change ) \text{Annual TCOC} = (\text{Dressing Unit Cost} \times \text{Annual Change Frequency}) + (\text{Nursing Hourly Rate} \times \text{Labor Hours per Change}) Annual TCOC = ( Dressing Unit Cost × Annual Change Frequency ) + ( Nursing Hourly Rate × Labor Hours per Change )

Economic Conclusion: Utilizing extended wear-time advanced dressings reduces total institutional cost by over 60% compared to daily wet-to-dry gauze, despite higher initial unit prices.

Medicare Local Coverage Determinations (LCDs) & DME Reimbursement

Outpatient wound care reimbursement for Durable Medical Equipment (DME)—including surgical dressings and Negative Pressure Wound Therapy (NPWT) pumps—is strictly governed by Medicare administrative contractors (MACs) through Local Coverage Determinations (LCDs) .

Surgical Dressings LCD Requirements

To qualify for Medicare Part B DME reimbursement, documentation must substantiate:

Wound etiology (e.g., full-thickness pressure injury, surgical wound, leg ulcer).

Exact wound measurements (Length × Width × Depth) updated every 7 to 30 days .

Exudate amount justifying the specific dressing category (e.g., heavy exudate documented to justify alginate coverage).

Quantitative limitations: Alginates limited to 30 dressings per 30 days; Foams limited to 12 dressings per 30 days.

Negative Pressure Wound Therapy (NPWT) LCD Criteria

Medicare reimbursement for NPWT requires clinical documentation fulfilling specific coverage benchmarks:

Diagnosis of a Stage 3 or Stage 4 pressure injury, severe neuropathic ulcer, chronic venous ulcer, or open dehisced surgical wound.

Documentation of 30-day failure of conventional wound therapy , including appropriate offloading, moist wound healing dressings, moisture control, and nutritional intervention.

Complete, detailed written orders (DWO) signed by a physician prior to billing.

Weekly wound evaluation: Documenting quantitative linear measurement progress. If no progress (PAR reduction) is documented over a 4-week window, Medicare coverage for NPWT is terminated.

Resource Optimization & Waste Reduction Strategies

Par-Level Inventory Control: Restrict clinical unit supply rooms to standardized formulary items, removing off-formulary stock.

Kitting System: Implement pre-packaged dressing kits for standard procedures (e.g., NPWT application kits, central line skin kits).

Staff Education & Decision Trees: Post visual formulary flowcharts on clinical units directing nurses to select dressings based on exudate level and tissue type.

Dressing Category Primary Mechanism Exudate Level Indication Maximum Wear Time Primary Clinical Contraindication

Alginates / Hydrofibers Gel-forming absorption Moderate to Heavy Up to 7 Days (Typically 1-3) Dry eschar, light/scant exudate (causes desiccation)

Hydrocellular Foams Semi-permeable cushioning Moderate to Heavy Up to 7 Days Dry wounds without fluid, third-degree burns

Hydrogels Donates moisture to bed Dry to Scant Up to 3 Days (24-72 hrs) Heavily exudative wounds (causes severe maceration)

Hydrocolloids Occlusive autolytic barrier Scant to Light Up to 7 Days Heavily exudative or actively infected wounds

Collagens Matrix substrate Light to Moderate Up to 7 Days Active wound infection, known bovine/porcine allergy

Ionic Silver Antimicrobials Sustained silver ion release Any Exudate Level Up to 7 Days (Max 14 days) Known silver allergy, MRI procedures (metallic)

Loading diagram... Formulary Selection & DME Reimbursement Compliance Decision Tree